title: Role of protein kinase C in TBT-induced inhibition of lytic function and MAPK activation in human natural killer cells.
abstract: Human natural killer (NK) cells are lymphocytes that destroy tumor and virally infected cells. Previous studies have shown that exposure of NK cells to tributyltin (TBT) greatly diminishes their ability to destroy tumor cells (lytic function) while activating mitogen-activated protein kinases (MAPK) (p44/42, p38, and JNK) in NK cells. The signaling pathway that regulates NK lytic function appears to include activation of protein kinase C(PKC) as well as MAPK activity. TBT-induced activation of MAPKs would trigger a portion of the NK lytic signaling pathway, which would then leave the NK cell unable to trigger this pathway in response to a subsequent encounter with a target cell. In the present study we evaluated the involvement of PKC in inhibition of NK lysis of tumor cells and activation of MAPKs caused by TBT exposure. TBT caused a 2–3-fold activation of PKC at concentrations ranging from 50 to 300 nM (16–98 ng/ml),indicating that activation of PKC occurs in response to TBT exposure. This would then leave the NK cell unable to respond to targets. Treatment with the PKC inhibitor, bisindolylmaleimide I, caused an 85% decrease in the ability of NK cells to lyse tumor cells, validating the involvement of PKC in the lytic signaling pathway. The role of PKC in the activation of MAPKs by TBT was also investigated using bisindolylmaleimide I. The results indicated that, in NK cells where PKC activation was blocked, there was no activation of the MAPK, p44/42 in response to TBT.However, TBT-induced activation of the MAPKs, p38 and JNK did not require PKC activation. These results indicate the pivotal role of PKC in the TBT-induced loss of NK lytic function including activation of p44/42 by TBT in NK cells.
authors.affiliation: Department of Biological Sciences, Tennessee State University, Nashville, TN 37209, USA.
authors.forename: Abraham B
authors.initials: AB
authors.lastname: Abraha
authors.forename: Krupa
authors.initials: K
authors.lastname: Rana
authors.forename: Margaret M
authors.initials: MM
authors.lastname: Whalen
mesh_terms: D003601:Cytotoxicity Tests, Immunologic; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D011493:Protein Kinase C / Q000378:metabolism*; D014220:Trialkyltin Compounds / Q000633:toxicity*
chemical_list: D014220:Trialkyltin Compounds; C011559:tributyltin; D011493:Protein Kinase C; D020928:Mitogen-Activated Protein Kinases
references.citation: Arch Toxicol. 2007 Apr;81(4):271-7
references.pmid: 17019560
references.citation: Cell Biol Toxicol. 2010 Oct;26(5):435-44
references.pmid: 20213532
references.citation: J Appl Toxicol. 2007 Jan-Feb;27(1):86-94
references.pmid: 17149696
references.citation: N Engl J Med. 1989 Jun 29;320(26):1731-5
references.pmid: 2543925
references.citation: Environ Pollut. 1995;90(3):279-90
references.pmid: 15091461
references.citation: Oncogene. 1997 Dec 11;15(24):2921-7
references.pmid: 9416835
references.citation: Cell Immunol. 1989 Feb;118(2):470-81
references.pmid: 2910505
references.citation: Circulation. 2005 Sep 27;112(13):1971-8
references.pmid: 16172266
references.citation: Biochem Biophys Res Commun. 2004 Mar 19;315(4):991-7
references.pmid: 14985110
references.citation: Science. 2004 Nov 26;306(5701):1517-9
references.pmid: 15567854
references.citation: Immunology. 1993 Aug;79(4):542-7
references.pmid: 8406578
references.citation: Environ Res. 1999 Aug;81(2):108-16
references.pmid: 10433842
references.citation: J Immunol. 1988 Nov 1;141(9):3164-9
references.pmid: 3262683
references.citation: Arch Dermatol. 1989 Oct;125(10):1406-12
references.pmid: 2679403
references.citation: J Immunol. 2001 Jun 15;166(12):7219-28
references.pmid: 11390470
references.citation: FASEB J. 1995 Apr;9(7):484-96
references.pmid: 7737456
references.citation: J Biol Chem. 1996 Feb 9;271(6):2886-91
references.pmid: 8621675
references.citation: Endocr Rev. 2001 Apr;22(2):153-83
references.pmid: 11294822
references.citation: Environ Res. 1987 Dec;44(2):335-53
references.pmid: 3319574
references.citation: J Immunol. 1986 Sep 15;137(6):1977-84
references.pmid: 2427588
references.citation: Int Immunol. 2004 Mar;16(3):385-93
references.pmid: 14978012
references.citation: Nat Immunol. 2000 Nov;1(5):419-25
references.pmid: 11062502
references.citation: Immunology. 2003 Jul;109(3):432-9
references.pmid: 12807490
references.citation: Environ Health Perspect. 1976 Apr;14:51-6
references.pmid: 789069
references.citation: J Biol Chem. 1992 Nov 25;267(33):23957-62
references.pmid: 1429733
references.citation: Cell Res. 2005 Jan;15(1):19-23
references.pmid: 15686621
references.citation: J Biol Chem. 1991 Aug 25;266(24):15771-81
references.pmid: 1874734
references.citation: Scand J Immunol. 2002 Mar;55(3):229-32
references.pmid: 11940228
references.citation: Cell Immunol. 1988 Apr 1;112(2):402-13
references.pmid: 2833358
references.citation: Trends Immunol. 2001 Nov;22(11):633-40
references.pmid: 11698225
references.citation: J Appl Toxicol. 2009 Mar;29(2):165-73
references.pmid: 18989867
references.citation: Nat Immunol. 2000 Nov;1(5):372-4
references.pmid: 11062493
references.citation: Toxicology. 2005 May 5;209(3):263-77
references.pmid: 15795062
references.citation: Nat Rev Mol Cell Biol. 2010 Feb;11(2):103-12
references.pmid: 20094051
references.citation: J Toxicol Environ Health A. 2001 Jun 22;63(4):273-87
references.pmid: 11437060
references.citation: Toxicol Appl Pharmacol. 1996 Jun;138(2):268-74
references.pmid: 8658528
references.citation: J Immunol. 2000 Aug 15;165(4):1782-9
references.pmid: 10925255
references.citation: J Exp Med. 1992 Dec 1;176(6):1751-5
references.pmid: 1281218
references.citation: J Immunol. 2000 Oct 1;165(7):3811-9
references.pmid: 11034387
references.citation: Toxicology. 2006 Jul 25;224(3):229-37
references.pmid: 16781040
references.citation: J Pediatr. 1982 May;100(5):727-30
references.pmid: 6279813
references.citation: Environ Res. 2002 Mar;88(3):199-209
references.pmid: 12051798
references.citation: J Toxicol Environ Health A. 1998 Nov 13;55(5):373-84
references.pmid: 9829560
references.citation: Bull Environ Contam Toxicol. 1995 Oct;55(4):510-6
references.pmid: 8555674
references.citation: Science. 1995 Feb 3;267(5198):682-5
references.pmid: 7839144
references.citation: J Immunol. 1998 Dec 15;161(12):6648-56
references.pmid: 9862693
references.citation: Adv Cancer Res. 2003;90:127-56
references.pmid: 14710949
references.citation: Environ Res. 2002 Jan;88(1):19-29
references.pmid: 11896664
references.citation: Nature. 1988 Aug 25;334(6184):661-5
references.pmid: 3045562